Matthew Wilson

Backing early-stage tech Founders who are creating Asymmetric returns in Atypical markets

[Matthew Wilson @matthewcwilson]

@matthew_sigel That's all great but have you ever pured a 300+ yard driver at a data center?

[OStateIllustrated.com @OKStateRivals]

🚨FALL CAMP DEAL🚨

Cowboy fans, time is limited on this deal! 75% off of your new OStateIllustrated/On3 annual subscription.

That's $30 for 12 months of scoop, message board community, all of the content from On3 and Rivals national teams.

Give us a shot and we'll earn your future business!

JOIN: https://t.co/M3OXKcUqta

[BowTiedMeatHead 🥩💪 @bowtiedmeathead]

Found out my 12 year son likes to use a new towel every night he takes a shower.

Nicely explained to him that the towel is not that wet and you can hang it up, let it dry and use it least once more before putting in the hamper.

He looked me like I have 5 heads.

Told him I sometimes use the same towel multiple times throughout the week before grabbing a new towel…

Curious what everyone else does and what is considered normal.

Do you use a new towel every time you take a shower or do reuse a clean towel at least once?

[Matthew Wilson @matthewcwilson]

But it’s just the price I pay
Destiny is calling me
Open up my eager eyes

[Matthew Wilson @matthewcwilson]

@SuaveCEO_ https://t.co/tz6ExJd7Jq

[Matthew Wilson @matthewcwilson]

A hill I will die on:

Seat A/C > seat warmer.

And it isn’t remotely close.

[Matthew Wilson @matthewcwilson]

We are about to find out what happens when the entire US eats the carnivore diet for a few weeks

[Polymarket @Polymarket]

NEW: Infectious disease doctor advises avoiding fresh produce — even if washed — as the explosive diarrhea outbreak spreads rapidly throughout the U.S.

[Matthew Wilson @matthewcwilson]

@geola388 @AndrewKSchlecht JWill came from Arkansas. Your AI generated response is bad.

[Matthew Wilson @matthewcwilson]

@geola388 @AndrewKSchlecht Swain shooting

[Matthew Wilson @matthewcwilson]

@usmntonly He’s a hot head. Can’t trust him. Has to earn it back the way Dest did.

[Matthew Wilson @matthewcwilson]

Disrupting things was cool until they got disrupted

[Anonymous @YourAnonNews]

Stanford grads walk out as Google CEO Sundar Pichai takes the stage as commencement speaker.

[Matthew Wilson @matthewcwilson]

AI comin for peoples jobs

[ClutchPoints @ClutchPoints]

The courtside angle of Anthony Edwards' poster dunk on John Collins 😯

(via gavmastagram/IG)

[Matthew Wilson @matthewcwilson]

I know the feeling my man

[Bleacher Report @BleacherReport]

Harrison Barnes missed Tuesday night's game because he woke up from a pregame nap with a sore left ankle (via @APNews)

It's the first time Barnes has missed a game since 2021, ending a streak of 364 consecutive games

[Matthew Wilson @matthewcwilson]

Potential Investor: What are your expected returns for the Fund?

Me:

[Matthew Wilson @matthewcwilson]

Loosely translates to...I'd like to speak with the manager please.

[Matthew Wilson @matthewcwilson]

@josh_schuchts @247SportsPortal @TransferPortal @rajesh_murti

[Matthew Wilson @matthewcwilson]

VCs across the country are hopeful

[Polymarket @Polymarket]

BREAKING: Trump considers eliminating taxes on gambling winnings.

[Matthew Wilson @matthewcwilson]

What comes next is the movie The Island

[Bryan Johnson @bryan_johnson]

I’m going to build an organoid avatar of myself.

Thousands of miniature Bryan Johnsons grown on cell culture dishes, each replicating my cellular and organ biology. This living model will let me test the efficacy of supplements, drugs, and nutrition to accelerate safe and measure progress against aging.

Details:
The potential of stem cell derived organoids is to enable toxicity screenings for drug discovery and complex treatment regiments. This same benefit can be realized for longevity supplementation, nutrition, and Rx protocols.

Becoming the most measured person in history allowed my organs to speak, but the drawback is that there’s only one copy of me for testing. This means I can only tweak one or a handful of variables at a time to explore their effects.

A single copy of me limits the number of things I can test simultaneously, slowing the speed of progress. These limitations can be resolved by scaling me up using personalized, stem cell-derived organoids.

We are currently giving this serious consideration. Here's a rough workflow:

A blood sample is taken, some cells are isolated (PBMCs) and reprogrammed into induced pluripotent stem cells (iPSCs). These cells are then propagated in cultures. Using special lab treatments and conditions, they are coaxed to differentiate and grow into mini-organs, or organoids.

These organoids carry my exact DNA. Although the reprogramming process erases most epigenetics acquired in my life, bringing the cells back to a newborn-like state, we can think of these organoids as "Baby Bryans" available to test interventions.

Organoid function and phenotype can be monitored using computational models, which can extrapolate the organoid's behavior to predict effects on the actual organs in my body.

These organoids can be hooked together into one artificial circulation, creating hundreds or thousands of "mini Bryans."

These will allow us to test each ingredient and intervention separately, as well as particular combinations.

The level of evidence and sophistication of organ-on-chip model has seen rapid progress in the last decade

Initial prototypes utilized interconnected 2-D and spheroid "organ-on-chip" cultures to successfully model the metabolism, toxicity, and biodistribution of drugs and their metabolites, including liver-kidney, liver-lung, and liver-brain interactions.

The use of induced pluripotent stem cells (iPSCs) coupled with 3D-printed scaffolds to generate spheroids and organoids paved the way for these systems in personalized medicine. This approach enables accurate, personalized, case-by-case predictions for drug interaction, efficacy, and toxicity.

These systems can even model systemic disease states, such as blood-brain barrier permeability, neurotoxicity, lung and pancreas cystic fibrosis, cancer metastasis, and responsiveness to chemotherapy.

The next iteration of organoids rely on computational models, promising to evolve these systems from modeling extreme toxicity and disease states to the more delicate field of predicting chronic toxicity and harms from drugs in development.

This granularity will enable optimization of personal drug and supplement regimens with cellular and molecular level accuracy, a feat normally challenging to track within the complexity of the living body.

The field is maturing from merely generating organoids to building in-silico avatars of one's body based on insights collected from cultured organoids. On the pharmaceutical side, these systems can already accelerate discovery by predicting drug candidate toxicity before they transition into expensive clinical trials.

On the longevity and personal health side, this means we will soon no longer have to speculatively test interventions and therapies on ourselves based solely on general population data. My organoid avatars will undertake the heavy lifting of detecting and predicting toxicity, harm, and likelihood of efficacy.

[Matthew Wilson @matthewcwilson]

I’m pretty sure the ordering kiosk at McDonald’s just laughed a little when I ordered a Diet Dr. Pepper with my double quarter pounder meal

[Matthew Wilson @matthewcwilson]

@dmnfood Someone please check in on @girdley